AJAY BANSAL is a Team Member at Mehta Partners. A seasoned industry
manager, he most recently worked with Arthur D. Little's pharmaceutical
consulting group and, prior to that, at Novartis, US and Switzerland.
Mr. Bansal served as Executive Director, Strategy and Special Projects,
in Ciba-Geigy's pharma division and holds Master's of Science degrees in
Management from Kellogg Graduate School of Management and in Engineering
and Operations Research from Northwestern University. He was a
significant participant in the Ciba-Chiron partnership and has extensive
consulting experience with Arthur D. Little and McKinsey & Company. Mr.
Bansal is proficient in German. Profile
TWST: Give us an overview of the main platform technology classes that
investors are looking at these days for biotechnology.
Mr. Bansal: The technology that really caught people's eyes over